Avalo Therapeutics AVTX SEC Filings

NASDAQ AVTX
$12.26 -0.10 (-0.81%)
At close: Oct 21, 2026 · 4:00 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Avalo Therapeutics, Inc. (AVTX) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
14Insider Transaction0001707797-26-000017Oct 2, 2026 12:15 AM
24Insider Transaction0001677036-26-000009Oct 2, 2026 12:15 AM
34Insider Transaction0002063957-26-000009Oct 2, 2026 12:15 AM
44Insider Transaction0001810417-26-000023Sep 18, 2026 8:10 PM
54Insider Transaction0001810417-26-000021Sep 11, 2026 8:10 PM
64Insider Transaction0001918845-26-000031Sep 1, 2026 8:38 PM
74Insider Transaction0001810417-26-000019Aug 19, 2026 8:10 PM
84Insider Transaction0001918845-26-000029Aug 19, 2026 8:10 PM
9144Insider Transaction0001950047-26-008317Aug 18, 2026 8:18 PM
10144Insider Transaction0001950047-26-008276Aug 17, 2026 8:49 PM
11144Insider Transaction0001950047-26-008273Aug 17, 2026 8:47 PM
12144Insider Transaction0001950047-26-008220Aug 17, 2026 8:18 PM
13SCHEDULE 13G/AOthers0000902664-26-003460Aug 14, 2026 9:00 AM
14SCHEDULE 13G/AOthers0001011438-26-000509Aug 13, 2026 4:06 PM
154Insider Transaction0002047607-26-000008Aug 12, 2026 8:10 PM
164Insider Transaction0001918845-26-000026Aug 12, 2026 8:10 PM
17144Insider Transaction0001950047-26-007948Aug 11, 2026 8:22 PM
18144Insider Transaction0001950047-26-007908Aug 10, 2026 8:47 PM
19SCHEDULE 13GBeneficial Ownership Report0000315066-26-002249Aug 7, 2026 3:04 PM
20SCHEDULE 13GBeneficial Ownership Report0000093751-26-000415Aug 7, 2026 12:44 PM
21SCHEDULE 13GBeneficial Ownership Report0000315066-26-001940Aug 6, 2026 2:14 PM
2210-QQuarterly & Annual Report0001534120-26-000049Aug 6, 2026 11:03 AM
238-KCurrent Report0001534120-26-000048Aug 6, 2026 11:01 AM
244Insider Transaction0001918845-26-000024Jul 29, 2026 8:05 PM
25EFFECTOthers9999999995-26-002480Jul 28, 2026 4:15 AM
26424B3Prospectus0001104659-26-087573Jul 28, 2026 8:41 PM
27SCHEDULE 13GBeneficial Ownership Report0002012383-26-002194Jul 27, 2026 8:25 PM
28S-3Prospectus0001104659-26-084609Jul 17, 2026 8:01 PM
29SCHEDULE 13GBeneficial Ownership Report0001104659-26-080836Jul 6, 2026 9:29 PM
304Insider Transaction0001918845-26-000022Jul 2, 2026 8:05 PM
314Insider Transaction0002063957-26-000007Jul 2, 2026 8:05 PM
324Insider Transaction0001677036-26-000006Jul 2, 2026 8:05 PM
334Insider Transaction0001707797-26-000014Jul 2, 2026 8:05 PM
344Insider Transaction0001918845-26-000020Jun 25, 2026 9:24 PM
354Insider Transaction0002063957-26-000005Jun 25, 2026 9:24 PM
363Insider Transaction0002063957-26-000004Jun 25, 2026 9:23 PM
378-KCurrent Report0001534120-26-000044Jun 23, 2026 11:01 AM
38SCHEDULE 13GBeneficial Ownership Report0001831942-26-000029Jun 18, 2026 8:29 PM
398-KCurrent Report0001534120-26-000042Jun 16, 2026 11:18 AM
404Insider Transaction0002047607-26-000006Jun 12, 2026 4:43 PM
414Insider Transaction0001677896-26-000008Jun 12, 2026 4:41 PM
424Insider Transaction0001810417-26-000016Jun 12, 2026 4:36 PM
434Insider Transaction0001918845-26-000018Jun 12, 2026 4:26 PM
448-KCurrent Report0001534120-26-000040Jun 12, 2026 4:06 PM
458-KCurrent Report0001534120-26-000036Jun 8, 2026 8:19 PM
46SCHEDULE 13GBeneficial Ownership Report0000315066-26-001408Jun 5, 2026 2:13 PM
474Insider Transaction0001677036-26-000004Jun 4, 2026 8:10 PM
484Insider Transaction0002017156-26-000004Jun 4, 2026 8:10 PM
494Insider Transaction0001247024-26-000004Jun 4, 2026 8:10 PM
504Insider Transaction0001862734-26-000004Jun 4, 2026 8:10 PM
...

Avalo Therapeutics, Inc. SEC Filings API

Pull Avalo Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=AVTX&formtype=10-K,10-Q&api_key=YOUR_API_KEY